|
 |
Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics
Y Ding, X Sun, M Redfield, S Kushwaha... - Cell Cycle, 2012 - Editorials: Cell Cycle Features. Target of rapamcyin (TOR)-based therapeutics for
cardiomyopathy: Insights from zebrafish genetics. Volume 11, Issue 3 February 1, 2012 Yonghe
Ding, Xiaojing Sun, Margaret Redfield, Sudhir Kushwaha and Xiaolei Xu. ...
Volume 11, Issue 3 February 1, 2012
Pages 428 - 429http://dx.doi.org/10.4161/cc.11.3.19164 View affiliations Hide affiliations Yonghe Ding Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester, MN USA Xiaojing Sun Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester, MN USA Margaret Redfield Division of Cardiovascular Diseases; Department of Medicine; Mayo Clinic College of Medicine; Rochester, MN USA Sudhir Kushwaha Division of Cardiovascular Diseases; Department of Medicine; Mayo Clinic College of Medicine; Rochester, MN USA Xiaolei Xu Corresponding author: xu.xiaolei@mayo.edu
Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester, MN USA
More Details:
Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics |
|
|
